Neurology residency program as factor associated with thrombolysis utilization in acute stroke.
Despite strong evidence on the safety and efficacy of IV alteplase up to 4.5 hours after ischemic stroke (IS) symptom onset and increased use of thrombolysis over recent decades, this treatment remains underused and accessible to only a fraction of patients. The rate of thrombolysis in the United States is 3.4%-5.2% of all stroke cases. Several studies have identified barriers to thrombolysis delivery, but other as yet unmeasured factors may also underlie these barriers, thereby influencing rates of thrombolysis utilization and access.